Apellis is a global biopharmaceutical company focused on developing innovative therapies that target the complement cascade to treat a range of diseases.
The company specializes in pioneering targeted C3 therapies for conditions in hematology, ophthalmology, and nephrology, with the goal of providing life-changing treatments for patients worldwide.
Generated from their website's infomation